comprehensive -WSS

comprehensive

author：leisure time 2025-09-06 05:26:43 - browse：467

Novo Nordisk Denmark — LISELOTTE SABROE/AFP/Getty Images

An oral version of semaglutide, the drug marketed as Ozempic and Wegovy, led to dramatic weight loss in a trial enrolling people with obesity, manufacturer Novo Nordisk said Monday, data that could bolster what is already a blockbuster medicine.

In the study, which enrolled nearly 700 adults classified as having overweight or obesity, patients treated with a daily semaglutide tablet lost 15.1% of their body weight over the course of 17 months, while those on placebo lost 2.4%, Novo Nordisk said. The result is comparable to weekly injections of Wegovy, which in an earlier study led to 14.9% weight loss over the same period of time. In both studies, the most common side effects were gastrointestinal distress, with the majority of cases graded mild or moderate, the company said.

Novo Nordisk said it plans to submit oral semaglutide for U.S. and E.U. approvals later this year. A lower-dose version of the drug is already approved as a treatment for type 2 diabetes under the brand name Rybelsus.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： White House launches permanent pandemic office

WSS

Russian special forces kill a gunman who broke into a private house near Moscow

What to know about Saharan dust affecting the US and how it can affect health

HIPAA doesn't protect reproductive records from prosecutors

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Body of missing toddler recovered in Delaware River days after flood: Police

Wikipedia

comprehensive

knowledge

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

ActiGraph execs on goal of drug approvals with digital endpoints

New air purifier tech could be key to improving indoor air quality

Baltimore teen accused of firing into crowd during block party mass shooting

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Hilary expected to bring catastrophic, life

Drug repurposing or repositioning? The language matters

Lung cancer is America's deadliest cancer. Yet so few get screened

Medicare details structure of new drug price negotiation program

A double vaccine crisis is endangering millions of children

hotspot

Congress must give Medicare recipients genetic counseling access

How artificial intelligence is being used to detect, treat cancer

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Why an extreme heat and wildfire smoke combination can be so dangerous

knowledge

hotspot

leisure time

explore